Save Life Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 100.00%
- Profit Growth 317.65%
- Ebitda 5.97%
- Net Worth 18.02%
- Total Assets -4.26%
About Save Life Pharmaceuticals
Save Life Pharmaceuticals Private Limited (SLPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 February 2014 and has a history of Ten years and 11 months. Its registered office is in North West Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rohit Bansal and Rohit Bisaria serve as directors at the Company.
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74140DL2014PTC265383
- Company No.
265383
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2014
- Date of AGM
19 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Save Life Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Bansal  | Director | 25-Feb-2014 | Current |
| Rohit Bisaria | Director | 25-Feb-2014 | Current |
Financial Performance of Save Life Pharmaceuticals.
Save Life Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 100% increase. The company also saw a substantial improvement in profitability, with a 317.65% increase in profit. The company's net worth Soared by an impressive increase of 18.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Save Life Pharmaceuticals?
Unlock access to Save Life Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rrj Logistics LlpRohit Bansal and Rohit Bisaria are mutual person
- Replin Llp
Rohit Bansal is a mutual person
- Phoenix Design & Events Private Limited
Rohit Bisaria is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Save Life Pharmaceuticals?
Unlock and access historical data on people associated with Save Life Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Save Life Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Save Life Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.